NO150884C - Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater - Google Patents

Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater

Info

Publication number
NO150884C
NO150884C NO770841A NO770841A NO150884C NO 150884 C NO150884 C NO 150884C NO 770841 A NO770841 A NO 770841A NO 770841 A NO770841 A NO 770841A NO 150884 C NO150884 C NO 150884C
Authority
NO
Norway
Prior art keywords
imidazotiazold
derivatives
preparation
therapeutically active
new therapeutically
Prior art date
Application number
NO770841A
Other languages
English (en)
Norwegian (no)
Other versions
NO150884B (no
NO770841L (no
Inventor
Jacques Louis Edouard Baetz
Original Assignee
Metabio Joullie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabio Joullie Sa filed Critical Metabio Joullie Sa
Publication of NO770841L publication Critical patent/NO770841L/no
Publication of NO150884B publication Critical patent/NO150884B/no
Publication of NO150884C publication Critical patent/NO150884C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO770841A 1976-03-10 1977-03-09 Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater NO150884C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9517/76A GB1541321A (en) 1976-03-10 1976-03-10 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation

Publications (3)

Publication Number Publication Date
NO770841L NO770841L (no) 1977-09-13
NO150884B NO150884B (no) 1984-09-24
NO150884C true NO150884C (no) 1985-01-09

Family

ID=9873507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770841A NO150884C (no) 1976-03-10 1977-03-09 Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater

Country Status (28)

Country Link
US (1) US4110460A (bg)
JP (1) JPS5927357B2 (bg)
AT (1) AT352716B (bg)
AU (1) AU503912B2 (bg)
BE (1) BE852259A (bg)
BG (1) BG28262A3 (bg)
CA (1) CA1074324A (bg)
CH (1) CH598267A5 (bg)
CS (1) CS190341B2 (bg)
DE (1) DE2709639A1 (bg)
DK (1) DK144702C (bg)
ES (1) ES456575A1 (bg)
FI (1) FI62313C (bg)
FR (1) FR2343748A1 (bg)
GB (1) GB1541321A (bg)
HU (1) HU172685B (bg)
IE (1) IE44280B1 (bg)
IL (1) IL51581A (bg)
LU (1) LU76879A1 (bg)
NL (1) NL7702446A (bg)
NO (1) NO150884C (bg)
PL (1) PL102603B1 (bg)
PT (1) PT66278B (bg)
RO (1) RO71301A (bg)
SE (1) SE431653B (bg)
SU (1) SU629882A3 (bg)
YU (1) YU61977A (bg)
ZA (1) ZA771303B (bg)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204067A (en) * 1976-09-24 1980-05-20 Adhikary Parimal K Derivatives of imidazo[2,1-b] thiazole
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
US4153706A (en) 1978-02-13 1979-05-08 Smithkline Corporation 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
PL221188A1 (bg) * 1979-01-05 1980-12-01 Ciba Geigy Ag
US4364942A (en) * 1979-06-21 1982-12-21 Janssen Pharmaceutica N.V. 2,3-Dihydro-imidazo (2,1-b)benzothiazoles compositions useful as anti-parkinsonism agents
FR2463774A1 (fr) * 1979-08-21 1981-02-27 Yamanouchi Pharma Co Ltd Derives du 2-phenylimidazo(2,1-b)benzothiazole
FR2479831A1 (fr) * 1980-04-08 1981-10-09 Synthelabo Derives de thiazole, leur preparation et leur application en therapeutique
US4327221A (en) * 1980-10-15 1982-04-27 American Home Products Corporation 2-Substituted-3-hydroxythiazolo(2,3-8)-thiazolium salts and mesoionic didehydro derivatives thereof
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
ZW24186A1 (en) * 1985-12-12 1987-07-08 Smithkline Beckman Corp Inhibition of the 5-lipoxygenase pathway
US5134150A (en) * 1985-12-12 1992-07-28 Smithkline Beecham Corporation Inhibition of the 5-lipoxygenase pathway
US4751310A (en) * 1985-12-12 1988-06-14 Smithkline Beckman Corporation Inhibition of the 5-lipoxygenase pathway
US4719218A (en) * 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
US5145858A (en) * 1985-12-12 1992-09-08 Smithkline Beecham Corp. Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4794114A (en) * 1986-08-19 1988-12-27 Smithkline Beckman Corporation Inhibition of interleukin-1 production by monocytes and/or macrophages
US5630014A (en) * 1993-10-27 1997-05-13 Nec Corporation Gain controller with automatic adjustment using integration energy values
US6127387A (en) * 1996-12-10 2000-10-03 Thomas Jefferson University Use of CD4-binding small molecules to inhibit immune responses
WO2007034282A2 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (bg) * 1964-05-11
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles
NL164285C (nl) * 1968-01-09 1980-12-15 Rhone Poulenc Sa Werkwijze ter bereiding van een farmaceutisch preparaat, dat een imidazoÿ2.1-bÿthiazoolderivaat bevat, de gevormde farmaceutische preparaten, alsmede werkwijze voor het bereiden van dit imidazoÿ2.1-bÿthiazoolderivaat.

Also Published As

Publication number Publication date
AU503912B2 (en) 1979-09-27
DK144702B (da) 1982-05-17
YU61977A (en) 1982-06-30
ATA164477A (de) 1979-03-15
CA1074324A (en) 1980-03-25
FI62313B (fi) 1982-08-31
DK104677A (da) 1977-09-11
JPS52136195A (en) 1977-11-14
GB1541321A (en) 1979-02-28
ZA771303B (en) 1978-01-25
SU629882A3 (ru) 1978-10-25
NO150884B (no) 1984-09-24
FR2343748A1 (fr) 1977-10-07
FI770759A (bg) 1977-09-11
DK144702C (da) 1982-10-11
SE7702503L (sv) 1977-09-11
LU76879A1 (bg) 1977-07-12
PT66278B (fr) 1978-08-08
CH598267A5 (bg) 1978-04-28
IE44280B1 (en) 1981-09-23
JPS5927357B2 (ja) 1984-07-05
CS190341B2 (en) 1979-05-31
ES456575A1 (es) 1978-02-16
PT66278A (fr) 1977-04-01
AT352716B (de) 1979-10-10
DE2709639A1 (de) 1977-09-15
RO71301A (ro) 1981-11-24
HU172685B (hu) 1978-11-28
BE852259A (fr) 1977-09-09
FI62313C (fi) 1982-12-10
NO770841L (no) 1977-09-13
FR2343748B1 (bg) 1980-07-18
IL51581A (en) 1980-02-29
IE44280L (en) 1977-09-10
US4110460A (en) 1978-08-29
PL102603B1 (pl) 1979-04-30
NL7702446A (nl) 1977-09-13
IL51581A0 (en) 1977-05-31
SE431653B (sv) 1984-02-20
AU2315677A (en) 1978-09-14
BG28262A3 (bg) 1980-03-25

Similar Documents

Publication Publication Date Title
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO148416C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO148926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO150279C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme benzopyranderivater
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner